Detalhe da pesquisa
1.
Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
Blood
; 143(12): 1157-1166, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142401
2.
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria.
Int J Mol Sci
; 24(11)2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298309
3.
Pregnancy in acquired bone marrow failure syndromes: Antenatal management and maternal and fetal outcomes.
Am J Hematol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38747646
4.
Terminal complement inhibition dampens the inflammation during COVID-19.
Br J Haematol
; 190(3): e141-e143, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495372
5.
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
Leukemia
; 37(12): 2479-2485, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794100
6.
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
Leukemia
; 35(11): 3223-3231, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664463
7.
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study.
Bone Marrow Transplant
; 56(10): 2600-2602, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226670